Croda Healthcare, Parsippany, NJ, has expanded its lipid production at the company’s Leek site in Staffs, U.K. The planned development will take place over the next 12-18 months and will double the manufacturing capacity. Extensive investment in purpose-built pharmaceutical facilities has taken place at the site, where Croda recently commissioned a GMP API (active pharmaceutical ingredient) Super Critical CO2 plant to produce lipids with greater than 95% purity.